What is Yonalink?
Yonalink operates at the intersection of health informatics and clinical research, providing a specialized platform designed to migrate clinical research data from electronic health records (EHR) directly into research databases. The platform is engineered to ensure that data transfer is automated, secure, and fully validated, effectively eliminating the manual errors that have historically plagued clinical data management. By bridging the gap between medical centers and research entities, Yonalink facilitates a more efficient, error-free, and trusted environment for pharmaceutical and academic research. Its market position is defined by its commitment to regulatory compliance and data integrity, which are essential for the adoption of digital health solutions in high-stakes clinical environments.
How much funding has Yonalink raised?
Yonalink has raised a total of $6M across 1 funding round:
Other Financing Round
$6M
Other Financing Round (2022): $6M with participation from Debiopharm Innovation Fund, eHealth Ventures, and European Union
Key Investors in Yonalink
Debiopharm Innovation Fund
A corporate venture capital firm that invests in digital health and smart data startups to improve patient outcomes and clinical trial efficiency.
eHealth Ventures
An early-stage digital health fund that focuses on optimizing venture building through strategic healthcare partnerships and a skilled professional team.
European Union
A supranational political and economic union that provides strategic funding and grants to foster innovation, economic cooperation, and technological advancement across member states.
What's next for Yonalink?
With this major enterprise-level funding, Yonalink is poised to accelerate its product development roadmap and expand its footprint in the digital health ecosystem. The company is expected to focus on enhancing its automated validation protocols and deepening its integration capabilities with major EHR providers. Strategic priorities likely include scaling its operational capacity to support larger, multi-center clinical trials and strengthening its commercial partnerships. As the industry moves toward more data-driven research methodologies, Yonalink's ability to provide a seamless, secure pipeline for clinical data will be a key driver of its long-term growth and competitive advantage in the healthcare technology landscape.
See full Yonalink company page
